(4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-N-carboxamide derivatives
The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain.
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
04.07.2013
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain. |
|---|---|
| AbstractList | The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain. |
| Author | CUMMING, JOHN WATERSON, DAVID FAULL, ALAN WELLINGTON |
| Author_xml | – fullname: CUMMING, JOHN – fullname: WATERSON, DAVID – fullname: FAULL, ALAN WELLINGTON |
| BookMark | eNrjYmDJy89L5WTw1zDRLUktKtFNKi2pzCnILEgtSqzKzNM10q3M0dRA8A1B_NzUkoxEkD5dP93kxKKk_IrE3MyUVIWU1KLMssSSzLLUYh4G1rTEnOJUXijNzaDi5hri7KGbWpAfn1pckJicmpdaEu8YamRgYGlsZG5qburkZGRMpDIAi385rg |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | AU2009327575BB2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_AU2009327575BB23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:59:06 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_AU2009327575BB23 |
| Notes | Application Number: AU20090327575 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130704&DB=EPODOC&CC=AU&NR=2009327575B2 |
| ParticipantIDs | epo_espacenet_AU2009327575BB2 |
| PublicationCentury | 2000 |
| PublicationDate | 20130704 |
| PublicationDateYYYYMMDD | 2013-07-04 |
| PublicationDate_xml | – month: 07 year: 2013 text: 20130704 day: 04 |
| PublicationDecade | 2010 |
| PublicationYear | 2013 |
| RelatedCompanies | ASTRAZENECA AB |
| RelatedCompanies_xml | – name: ASTRAZENECA AB |
| Score | 2.9020507 |
| Snippet | The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-N-carboxamide derivatives |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130704&DB=EPODOC&locale=&CC=AU&NR=2009327575B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3da8IwED_EjW1vm9vYl8MHKe4hrDap1QcZ64fIwA-GDt8kaVMQqhat2_zvdwl1-rS95RI4kpDL3eVyvwOoxswWnMUxobYjCePMIRy1MrYaIa0rCPCGykbu9RvdMXub2JMCJLtcGI0T-qXBEVGiQpT3TN_X6f4Ry9d_K9fPYoZdy5fOqO0buXdcVyeYGb7bDoYDf-AZnoeepNF_10EAajlonLh4YR8pQ1oh7QcfrspLSQ-VSuccjofIb5FdQEEuSnDq7WqvleCkl4e8sZlL3_oSBjVGVAifiE22TdJZKlcKHJpYZJs81fZ0XdGqNDRH316SPgn5Siy_-RwXXInwyH1qtO_1FVQ7wcjrEpzZ9Hcjpq_jg2W4Fr2GouJzA5WYmhFtMTSVech4y2zGkTQd0aSch7FFo1so_8nq7p_xezizdB0Ih5jsAYrZaiPLqI0z8ag38QcmZo36 |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dT8IwEL8QNOKbokZUlAey4EPjthYGD8S4DYIKGzHD8LZ0XwkJwgJD5b_32oDwpG_9SC5t0-v11-v9DqCasHrAWZIQWjdiwjgzCEerjKVGSDVBAd4Q0cgDp9EbsZdxfZyD6TYWRvKEfklyRNSoEPU9k-d1unvEsuXfyuVDMMGm-WPXa9vKBh1rYgczxTbbnaFru5ZiWYgkFedNOgGobuDlxMQD-8BAUCjB0rsp4lLSfaPSPYHDIcqbZaeQi2dFKFjb3GtFOBpsXN5Y3Gjf8gzcGiPChU-CVbaeppM0XghyaKKT9fS-tqtroi5SQ3PE9jFxSMgXwfybf-CEKxFuuU_J9r08h2q341k9giPzfxfCfxrtTcPU6QXkhZxLqCRUjWiL4VWZh4y31GYSxaoRNCnnYaLTqATlP0Vd_dN_B4WeN-j7_Wfn9RqOdZkTwiAqu4F8tljFZbTMWXArF_QH70iQ5A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%284-tert-butylpiperazin-2-yl%29%28piperazin-1-yl%29methanone-N-carboxamide+derivatives&rft.inventor=CUMMING%2C+JOHN&rft.inventor=WATERSON%2C+DAVID&rft.inventor=FAULL%2C+ALAN+WELLINGTON&rft.date=2013-07-04&rft.externalDBID=B2&rft.externalDocID=AU2009327575BB2 |